Skip to content
LEIatlas

LEI record

· United States

Salix Pharmaceuticals, Ltd.

Salix Pharmaceuticals, Ltd. in WILMINGTON — Lapsed LEI 549300IIP8FMEZXA0183, registered 2013.

Changes recorded by LEIatlas since 6 Jul 2026: updated its address on 5 Sep 2026. GLEIF publishes only the current record.

LapsedActive
5493
00
IIP8FMEZXA01
83
Issuer (LOU)
Res.
Entity identifier
Check
Legal form
Corporation
Jurisdiction
United States
Registered
20 Dec 2013
Next renewal
16 Dec 2014

Reference data

Identity

LEI
549300IIP8FMEZXA0183
ISINs
US7954351067 · US7954352057 · US795435AA40and 3 more →
Legal form
CorporationXTIQ
Registration authority
RA000602entity ID 3473908
Legal address
1521 CONCORD PIKE SUITE 201, WILMINGTON, 19803, US
HQ address
8510 Colonnade Center Drive, Raleigh, US
Initial registration
20 Dec 2013
Last updated
3 Sep 2026
Managing LOU (issuer)
Bloomberg Finance L.P.5493001KJTIIGC8Y1R12

Level 2 · who owns whom

Corporate structure

Direct accounting consolidation parent: Natural persons
Ultimate accounting consolidation parent: Natural persons

Securities & codes

Securities and identifiers

Securities (ISIN) · 6
US7954351067 · US7954352057 · US795435AA40 · US795435AB23 · US795435AD88 · US795435AE61
An ISIN (ISO 6166) identifies a single security, such as a share or a bond; the LEI identifies the legal entity behind it. In GLEIF’s ISIN-to-LEI relationship file, Salix Pharmaceuticals, Ltd. is the issuer of 6 ISINs. Any of them can be looked up with the ISIN lookup or directly at leiatlas.com/isin/US7954351067, which resolves to this page.

The archive · 2 versions

Change history

  1. 5 Sep 2026 – current
    • Address: earlier address (not shown)→current address (above)
  2. 6 Jul 2026 – 5 Sep 2026
    First recorded version.

What this means

What the record says about Salix Pharmaceuticals, Ltd.

Salix Pharmaceuticals, Ltd. is a Corporation in WILMINGTON, United States with 6 ISIN-identified securities mapped to its LEI, which is how regulators tie a traded instrument to the issuer behind it.

The LEI has been on record for 12 years, since 20 Dec 2013. That is about 5 years earlier than the median LEI in United States, which dates from 2019 — an early adopter by local standards.

Annual re-validation is 4356 days overdue: it fell due 16 Dec 2014. An LEI that is not re-validated lapses, which does not invalidate it but marks the reference data as unverified.

This archive holds 2 versions of the record. The most recent change was on 5 Sep 2026 and altered the address; the oldest version we hold dates from 6 Jul 2026. GLEIF publishes only the current state, so superseded values are not available from the source.

The LEI is issued and maintained by Bloomberg Finance L.P., one of the Local Operating Units accredited by GLEIF.

Beyond the LEI, 6 ISINs are mapped to this entity in the GLEIF cross-reference files.

No direct accounting-consolidating parent is reported, because its parent is one or more natural persons, who are outside the LEI system. GLEIF requires this to be stated explicitly rather than left blank, so the absence is itself a data point.

No ultimate accounting-consolidating parent is reported, because its parent is one or more natural persons, who are outside the LEI system. GLEIF requires this to be stated explicitly rather than left blank, so the absence is itself a data point.

The LEI registration is lapsed, and the entity status (active) records whether the legal entity itself still exists. The two are independent: an LEI can lapse while the company trades on, and it can stay issued after the company has been dissolved.

The mesh

Related entities

Source: GLEIF (CC0)Official record ↗More in United States